News

Novasep-PharmaZell Invests €7.3M to Increase API Production Capacity

August 02, 2022

Novasep-PharmaZell will increase API production capacity at its Mourenx site with €7.3M investment.

Navigating the Future

August 02, 2022

Promising applications for targeted delivery may be cresting the horizon.

New Guidance on the Use of Real-World Evidence

August 02, 2022

Pharma’s leveraging real-world evidence to drive product approval, reimbursement, and market access.

FDA Confirms Ongoing Reliance on Remote Inspection Methods

August 02, 2022

FDA’s hybrid inspection model will remain a regular means for supplementing onsite inspections and will be further integrated into the agency’s oversight operations.

Demerger and the Future

August 02, 2022

GSK has completed its demerger of Haleon and has signed an agreement to help support future pandemic preparedness in Europe.

The Stick and Carrot of Quality Management

August 02, 2022

How can we fix the quality manufacturing issues that come with product shortages?

DuPont Opens Biopharma Tubing Manufacturing Site in South Carolina

August 01, 2022

DuPont’s new manufacturing site will expand its biopharmaceutical tubing manufacturing capabilities.

The US Purchases 66 Million Doses of Moderna’s COVID-19 Vaccine for $1.74 Billion

August 01, 2022

The United States has agreed to purchase 66 million doses of Moderna’s bivalent COVID-19 booster candidate for $1.74 billion.

European Commission Approves AbbVie Axial Spondyloarthritis Treatment

August 01, 2022

The European Commission has approved Rinvoq (upadacitinib) for treatment of active non-radiographic axial spondyloarthritis.

PTC Granted Marketing Authorization by European Commission for AADC Deficiency Treatment

August 01, 2022

The European Commission has granted marketing authorization to Upstaza (eladocagene exuparvovec) for treatment of aromatic L-amino acid decarboxylase (AADC) deficiency.